Form 4: Dexcom Director Sells Shares
Insider Transaction (Form 4)
Nicholas Augustinos, a Director of Dexcom Inc, sold 8,089 shares of common stock on September 14, 2026.
Summary
- Open-market sale: disposed of 1,550 Common Stock at $84.02 ($130,231) on September 14, 2026; holds 35,832 after (Indirect).
- Open-market sale: disposed of 6,539 Common Stock at $84.04 ($549,538) on September 15, 2026; holds 29,293 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $679,769 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Nicholas Augustinos — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Open-market sale | Common Stock | 1,550 | $84 | $130.2K | 35,832 |
| 2026-09-15 | Open-market sale | Common Stock | 6,539 | $84 | $549.5K | 29,293 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Open-market sale (1,550 shares) |
| 2026-09-15 | Open-market sale (6,539 shares) |
Keywords
insider transaction, Form 4, DXCM, DEXCOM INC, bearish, Nicholas Augustinos
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.